Vertaling van "launched in december " (Nederlands → Frans) :

Forward, a Group-wide project launched in December 2007, provided annual cost savings of approximately USD 1.1 billion in 2008, exceeding the target of USD 670 million, that included procurement savings ahead of plan.
Lancé dans l’ensemble du groupe en décembre 2007, le projet Forward a permis de réaliser des économies d’USD 1,1 milliard environ en 2008, dépassant l’objectif d'USD 670 millions grâce à des économies d’approvisionnement en avance sur le plan.

Onbrez Breezhaler (QAB149) (USD 3 million) a once-daily long-acting bronchodilator for adult patients with chronic obstructive pulmonary disease (COPD), was launched in Germany in December 2009 as well as Ireland and Denmark in March 2010 after European regulatory approval in November 2009.
Onbrez Breezhaler (QAB149) (USD 3 millions), un bronchodilatateur à action prolongée en inhalation unique quotidienne destiné aux adultes atteints de broncho-pneumopathie chronique obstructive (BPCO), a été lancé en Allemagne en décembre 2009 ainsi qu’en Irlande et au Danemark en mars 2010, après l’obtention de son autorisation en Europe en novembre 2009.

QAB149 (indacaterol), a once-daily long-acting bronchodilator for adult patients with chronic obstructive pulmonary disease (COPD), gained European regulatory approval in November 2009 as Onbrez Breezhaler and was launched in Germany in December.
QAB149 (indacatérol), un bronchodilatateur à action prolongée en inhalation unique quotidienne destiné aux adultes atteints de broncho-pneumopathie chronique obstructive (BPCO), a été autorisé, en novembre 2009, en Europe sous le nom de Onbrez Breezhaler et a été lancé en Allemagne en décembre.

NEW YORK , N.Y., December 12 - Pfizer Inc. announced that Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today .
NEW YORK , N.Y., December 12 - Pfizer Inc. announced that Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today .